Persea Americana for Total Health (PATH ) Study (PATH)
Investigating the Effects of Avocado Intake on Metabolism and Cognition: A Systems Approach
Sponsor: Hass Avocado Board
Listed as NCT02740439, this NA trial focuses on Insulin Resistance and Insulin Sensitivity and remains ongoing. Sponsored by Hass Avocado Board, it has been updated 6 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Mar 2019 — Jan 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — Mar 2019 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hass Avocado Board
- University of Illinois at Urbana-Champaign
For direct contact, visit the study record on ClinicalTrials.gov .